selfotel has been researched along with Brain Ischemia in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (89.47) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Craddock, SD; Holtz, ML; Minger, SL; Pettigrew, LC | 1 |
Barber, PA; Buchan, AM; Hill, MD; Hoyte, L | 1 |
Kanthan, R; Shuaib, A; Waqar, T; Wishart, T | 1 |
Hakim, AM; Hogan, MJ; Takizawa, S | 1 |
Giffard, RG; Maier, CM; Pérez-Pinzón, MA; Steinberg, GK; Sun, GH; Yoon, EJ | 1 |
Clark, W; Coull, B; Goldstein, LB; Grotta, J; LaRue, L; Mackay, B; Meissner, I; Murphy, D; Pettigrew, LC | 1 |
Gaspary, HL; Graham, SH; Simon, RP | 1 |
Allegrini, PR; Fagg, GE; Sauer, D | 1 |
Scatton, B | 1 |
Ijaz, S; McCrea, S; Shuaib, A; Wishart, T | 1 |
Ijaz, S; Mazagri, R; Senthilsevlvan, A; Shuaib, A | 1 |
Albers, GW; Davis, SM; Diener, HC; Lees, KR; Norris, J | 1 |
Kometani, M; Nakao, K; Okada, M; Ueda, H | 1 |
Löscher, W; Szabo, L; Wlaź, P | 1 |
Arias, RL; Bowlby, MR; Tasse, JR | 1 |
Gjedde, A; Hakim, AM; Hogan, MJ | 1 |
Hakim, AM; Hogan, M; Takizawa, S | 1 |
Meldrum, BS; Swan, JH | 1 |
Dedman, JR; Earls, RM; Grotta, JC; Picone, CM; Rhoades, HM; Strong, RA; Yao, LP | 1 |
2 review(s) available for selfotel and Brain Ischemia
Article | Year |
---|---|
The rise and fall of NMDA antagonists for ischemic stroke.
Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanidines; Humans; Indoles; Ischemia; N-Methylaspartate; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Stroke | 2004 |
Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.
Topics: Animals; Brain Ischemia; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Humans; Pipecolic Acids; Piperidines; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate | 1994 |
2 trial(s) available for selfotel and Brain Ischemia
Article | Year |
---|---|
Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Central Nervous System; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate | 1995 |
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed.
Topics: Aged; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pipecolic Acids; Treatment Outcome | 1997 |
15 other study(ies) available for selfotel and Brain Ischemia
Article | Year |
---|---|
Glutamate receptor antagonists modulate heat shock protein response in focal brain ischemia.
Topics: Animals; Brain Ischemia; Excitatory Amino Acid Antagonists; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; HSP72 Heat-Shock Proteins; Infarction, Middle Cerebral Artery; Male; Pipecolic Acids; Quinoxalines; Rats; Rats, Inbred SHR | 2003 |
Post-ischemic therapy with CGS-19755 (alone or in combination with hypothermia) in gerbils.
Topics: Animals; Brain Ischemia; Combined Modality Therapy; Gerbillinae; Hypothermia, Induced; Injections, Intraperitoneal; Male; Maze Learning; N-Methylaspartate; Pipecolic Acids; Prosencephalon | 1995 |
In vitro binding of [3H]nimodipine and [3H]CGS-19755 to rat brain in focal cerebral ischemia.
Topics: Animals; Autoradiography; Binding Sites; Binding, Competitive; Brain; Brain Ischemia; Male; N-Methylaspartate; Nimodipine; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Tritium | 1995 |
Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Evoked Potentials, Somatosensory; In Vitro Techniques; Magnetic Resonance Imaging; Male; Mice; N-Methylaspartate; Neuroprotective Agents; Neurotoxins; Pipecolic Acids; Rabbits | 1995 |
BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis.
Topics: Analysis of Variance; Animals; Binding, Competitive; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Hippocampus; Injections, Intraperitoneal; Injections, Intravenous; Male; Microdialysis; N-Methylaspartate; Necrosis; Neurons; Observer Variation; Pipecolic Acids; Prosencephalon; Pyrimidines; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Reperfusion Injury | 1994 |
The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Topics: 2-Amino-5-phosphonovalerate; Animals; Blood Pressure; Brain Ischemia; Dizocilpine Maleate; Dose-Response Relationship, Drug; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Pipecolic Acids; Piperazines; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate | 1994 |
Mortality in gerbils with repetitive ischemia: CGSGS-19755/hypothermia therapy.
Topics: Animals; Brain Ischemia; Cell Death; Combined Modality Therapy; Gerbillinae; Hypothermia, Induced; Male; N-Methylaspartate; Neurons; Pipecolic Acids; Prosencephalon; Recurrence | 1994 |
CGS-19755 is neuroprotective during repetitive ischemia: this effect is significantly enhanced when combined with hypothermia.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Combined Modality Therapy; Gerbillinae; Hippocampus; Hypothermia, Induced; Male; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Recurrence; Severity of Illness Index; Substantia Nigra | 1993 |
Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Brain Ischemia; Cats; Cerebral Infarction; Excitatory Amino Acid Antagonists; Image Processing, Computer-Assisted; Male; Neuroprotective Agents; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate | 1997 |
Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.
Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Brain Ischemia; Cerebrovascular Disorders; Dizocilpine Maleate; Injections, Intraperitoneal; Male; Pipecolic Acids; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1998 |
Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hypoxia; Male; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 1999 |
In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Electrocoagulation; Male; N-Methylaspartate; Pipecolic Acids; Rats; Rats, Inbred Strains; Reference Values; Tissue Distribution | 1992 |
The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Hydrogen-Ion Concentration; Male; N-Methylaspartate; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Protection by NMDA antagonists against selective cell loss following transient ischaemia.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Brain; Brain Ischemia; Dibenzocycloheptenes; Dizocilpine Maleate; Male; N-Methylaspartate; Neurons; Pipecolic Acids; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
Neuronal protection correlates with prevention of calcium-calmodulin binding in rats.
Topics: Animals; Brain Ischemia; Calcium; Calmodulin; Hippocampus; Neurons; Nicardipine; Nimodipine; Pipecolic Acids; Piperidines; Rats | 1990 |